Deans' stroke musings: Brain death evaluation during the pandemic

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Saturday, August 1, 2020

Brain death evaluation during the pandemic

If you present to a hospital with locked-in-syndrome you better hope this is known about and followed.

How Should Doctors Determine Brain Death? January 2019

AAN calls for uniform, guideline-based policies and practices

The latest here:

Brain death evaluation during the pandemic

, Alexander Rae-Grant,

First published July 30, 2020, DOI: https://doi.org/10.1212/WNL.0000000000010544

Full PDF

Citation

Permissions

Make Comment

See Comments

Downloads

Abstract

Coronavirus Disease 2019 (COVID-19) may pose unique challenges to clinicians attempting to diagnose brain death in patients infected with the SARS-CoV-2. Among these challenges is the risk of aerosol generation during the traditional apnea testing using the insufflation technique, in addition to the risk of complications due to SARS-CoV-2-related lung disease. In this article, we discuss these challenges and provide further guidance to minimize such risks in order to ensure safety of health care professionals and other patients. We also emphasize the importance of maintaining the standards of brain death determination in this critical time.